Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RN7SKP299 is a processed pseudogene similar in sequence to the 7SK small nuclear RNA gene (RN7SK), which encodes a non-coding RNA that regulates transcription elongation by RNA polymerase II through the 7SK snRNP and control of the P-TEFb complex[1][3][4]. As a pseudogene, RN7SKP299 is not expressed as an active molecule, does not encode a functional RNA or protein, and has no known biological activity, disease relevance, or druggability. The naming implies homology to the functional RN7SK locus, but pseudogenes are typically non-functional remnants of duplicated or processed genes in the genome[3]. Note: If your intent was to refer to the functional 7SK small nuclear RNA (RN7SK), that molecule has a well-defined role in transcription regulation but is not a therapeutic target, receptor, or enzyme. Pseudogenes such as RN7SKP299 are not functional targets and are generally not relevant in drug discovery or disease biology[3][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, 7SK small nuclear pseudogene 299 (RN7SKP299).